肿瘤标志物与胰腺癌相关性的研究进展  

Research Progress in Correlation with Tumor Makers and Pancreatic Cancer

作　　者：张泉东 金政锡[2] 郝迪斯[2] 

机构地区：[1]佳木斯大学普外科,154007 [2]黑龙江省医院普外一科,哈尔滨150030

出　　处：《国际免疫学杂志》2014年第1期57-60,共4页International Journal of Immunology

摘　　要：胰腺癌（PC）是一种恶性程度极高的消化系统肿瘤，由于其生长的无痛性与隐匿性，且没有真正有效的常规检查与特异且敏感的肿瘤标志物，使得胰腺癌病人常在晚期才被诊断，而这时他们已失去了手术的最佳时机，因此寻找肿瘤早期标志物具有重要意义。由于胰腺癌标志物如趋化因子及受体、磷脂酰肌醇蛋白聚糖-1等的联合检测可能对胰腺癌早期诊断与预后评估具有很大价值，因而有待进一步研究。Pancreatic cancer is a type of tumors of digestive system with high malignancy. Symptoms often do not appear until the cancer has advanced to the late stage. Delayed diagnosis of pancreatic cancer is also related with that. There are no specific and sensitive markers for this disease. Therefor, it is important to look for early turner markers. Studies have found that the potential diagnostic value of the molecules, such as glypican-1, chemokines and ehemokine receptors.

关 键 词：胰腺癌 标志物 趋化因子及受体 磷脂酰肌醇蛋白聚糖-1 

分 类 号：R735.9[医药卫生—肿瘤]